SkinHealth Systems Inc.
SKIN Consumer Defensive Household & Personal Products
SkinHealth Systems Inc.’s revenue for fiscal 2025 (year ended December 2025) was $300.8 million, down 10.0% from fiscal 2024.
- Revenue
- −2.10%
- EPS
- −112.5%
- Free cash flow
- +19.1%
- Total debt
- −33.1%
Quarter to September 2026, against a year earlier
Follow SKIN
Alert me
SkinHealth Systems Inc. (SKIN) EV/Sales
As of 5 November 2026, SkinHealth Systems Inc. (SKIN) trades at a EV/Sales of 1.0×. Over the past ten years it has ranged from 0.0× (June 2021) to 18.1× (November 2021); the current reading is higher than 25% of that period. That is below the Household & Personal Products industry median of 1.2× and above the Consumer Defensive sector median of 1.0×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 1.0× | (11.05%) |
| FY2024 | 1.1× | (27.11%) |
| FY2023 | 1.6× | (62.40%) |
| FY2022 | 4.2× | (52.59%) |
| FY2021 | 8.8× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Sep 2026 | 1.1× | 38.47% |
| Jun 2026 | 0.8× | (7.86%) |
| Mar 2026 | 0.9× | (16.20%) |
| Dec 2025 | 1.0× | (23.16%) |
| 21 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| DSY Big Tree Cloud Holdings Limited compare | n/m |
| ATTT Atlas Trinity Tech Limited compare | n/m |
| YSG Yatsen Holding Limited Sponsored ADR compare | 0.1× |
| NUS Nu Skin Enterprises, Inc. compare | 0.2× |
| GROV Grove Collaborative Holdings, Inc. compare | 0.3× |
| SKIN SkinHealth Systems Inc. | 1.0× |
| ACU Acme United Corporation. compare | 1.4× |
| SLSN Solesence, Inc. compare | 1.5× |
| UG United-Guardian, Inc. compare | 1.9× |
| Household & Personal Products industry median | 1.2× |
| Consumer Defensive sector median | 1.0× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)